Janus Henderson Group PLC reduced its position in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 11.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 133,272 shares of the specialty chemicals company’s stock after selling 17,579 shares during the period. Janus Henderson Group PLC’s holdings in Innospec were worth $9,732,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also modified their holdings of the company. Hantz Financial Services Inc. raised its holdings in shares of Innospec by 271.0% in the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company’s stock valued at $44,000 after buying an additional 420 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Innospec by 1,159.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after acquiring an additional 487 shares during the period. Danske Bank A S purchased a new position in Innospec during the 3rd quarter valued at about $46,000. Caitong International Asset Management Co. Ltd grew its position in Innospec by 316.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 662 shares of the specialty chemicals company’s stock valued at $51,000 after acquiring an additional 503 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its position in Innospec by 125.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 728 shares of the specialty chemicals company’s stock valued at $56,000 after acquiring an additional 405 shares in the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.
Innospec Trading Up 6.1%
Shares of IOSP stock opened at $91.96 on Thursday. The firm has a fifty day moving average price of $83.41 and a 200 day moving average price of $79.56. The company has a market cap of $2.26 billion, a P/E ratio of 18.77, a PEG ratio of 2.39 and a beta of 0.93. Innospec Inc. has a 12 month low of $65.51 and a 12 month high of $93.34.
Analyst Ratings Changes
A number of analysts have issued reports on the stock. Weiss Ratings upgraded shares of Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 1st. Zacks Research upgraded shares of Innospec from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th. Finally, Wall Street Zen raised shares of Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, July 18th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold”.
Check Out Our Latest Report on IOSP
About Innospec
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
See Also
- Five stocks we like better than Innospec
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
